CVIA Journal

Cardiovascular Innovations and Applications

29th great wall International conference GWICC

ESC @ GW-ICC Joint Forum – Great Wall International Congress of Cardiology (GW-ICC) 2017- Heart Failure

It has become a tradition for world renowned cardiology associations to send delegations to GW-ICC congresses.

Professor Jeroen J. Bax, President, European Society of Cardiology (ESC), Professor John Warner, President, American Heart Association (AHA), and Professor Mary N. Walsh, President, American College of Cardiology (ACC), led delegations attending the 28th GW-ICC, to present latest international guidance, cutting-edge diagnosis and information on treatment with emerging technologies.

Cooperation with these international societies is not limited to their attendance at GW-ICC; GW-ICC also holds reciprocal academic sessions at the annual meetings of these eminent societies, for example GW-ICC @ ACC, GW-ICC @ AHA, and GW @ ESC, to introduce important Chinese academic research.

At the 28th GW-ICC in 2017, the ESC @ GW-ICC Joint Forum, which was held over four sessions, focused on the highlights of 2017 ESC Congress, to introduce the latest guidance and discuss the latest developments of ESC images, heart disease, heart failure, STEMI and valve disease.

A video of one of these 2017 sessions is now available to view on the GW-ICC YouTube channel:

Heart Failure

Presenter: Michel Komajda, Institute of Cardiometabolism and Nutrition (ICAN), Pierre & Marie Curie Paris VI University, Pitié‐Salpétrière Hospital Paris, France.

In this presentation Professor Komajda reviews heart failure topics from ESC 2017:

  • Beta blockers, heart rate and atrial fibrillation – afib affects outcomes; BB effects heterogenous
  • LVEF and beta blockers – BB post MI prevent HfrEF, reduce mortality in HFmrEF
  • Mineralocorticoid receptor antagonists/Potassium – MRAs work in high risk patients, hyperkalemia a problem, potential role of potassium binders
  • Adherence to guidelines and outcomes – adherence to guidelines is associated with favorable long-term outcomes in HfrEF
  • Diabetes – SGLT2 inhibitors, outcome trials on the way, mechanism unclear
  • Exergaming – new approach to improve exercise and beyond
  • AF ablation in HF – AF ablation beneficial in HfrEF

Further information on the 29th GW-ICC, to be held October 11th -14th, 2018, in Beijing, China, is available on the congress website:

http://www.gw-icc2017.org/en/1/index.jsp

Cardiovascular Innovations and Applications (CVIA) is the official journal of the Great Wall International Cardiology Conference (GW-ICC). CVIA supports GW-ICC in its aims of leading the development of cardiovascular medicine in China, by introducing and promoting new concepts and technologies and strengthening and promoting cooperation amongst Chinese and international cardiology experts. CVIA is available on the IngentaConnect platform http://www.ingentaconnect.com/content/cscript/cvia and at http://cvia-journal.org/. Submissions may be made using Scholar One manuscripts at https:/mc04.manuscriptcentral.com/cvia-journal. There are no author submission or article processing fees.

Twitter: @CVIA_Journal

Facebook: https://www.facebook.com/cvia.journal/

Conference website: http://www.gw-icc2017.org/en/1/index.jsp

Updated: September 26, 2018 — 12:54 pm
Cardiovascular Innovations and Applications is indexed in the SCOPUS, ESCI, OCLC, Primo Central (Ex Libris), Sherpa Romeo, NISC (National Information Services Corporation), DOAJ and Index Copernicus Databases
EX-Lib-90x50 OCLC-90x50 sherpa
NISC logo Directory of Open Access Journals index-copernicus logo
CVIA Journal © 2015